Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acyl-Coenzyme A: Cholesterol Acyltransferase (ACAT) in Cholesterol Metabolism: From Its Discovery to Clinical Trials and the Genomics Era. | Metabolites | 2021 | 34436484 | PubTator, text mining | PubMed |
| Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States. | Front Immunol | 2021 | 34434191 | PubTator, text mining | PubMed |
| Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation. | PLoS One | 2021 | 34428256 | PubTator, text mining | PubMed |
| Mammalian lipids: structure, synthesis and function. | Essays Biochem | 2021 | 34415021 | PubTator, text mining | PubMed |
| Implications of zonal architecture on differential gene expression profiling and altered pathway expressions in mandibular condylar cartilage. | Sci Rep | 2021 | 34413358 | PubTator, text mining | PubMed |
| Inborn errors of metabolism associated with 3-methylglutaconic aciduria. | Clin Chim Acta | 2021 | 34411555 | PubTator, text mining | PubMed |
| Inverse molecular docking reveals a novel function of thymol: Inhibition of fat deposition induced by high-dose glucose in Caenorhabditis elegans. | Food Sci Nutr | 2021 | 34401075 | PubTator, text mining | PubMed |
| Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism. | Cell Death Dis | 2021 | 34385421 | PubTator, text mining | PubMed |
| Does carnitine supplementation truly increase whole-body fat oxidation in older male adults during moderate-intensity exercise? | Aging Cell | 2021 | 34382748 | PubTator, text mining | PubMed |
| Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1. | Nutrients | 2021 | 34371910 | PubTator, text mining | PubMed |
| The extract of Ilex kudingcha inhibits atherosclerosis in apoE-deficient mice by suppressing cholesterol accumulation in macrophages. | Biosci Biotechnol Biochem | 2021 | 34369980 | PubTator, text mining | PubMed |
| High-Density Lipoproteins in Kidney Disease. | Int J Mol Sci | 2021 | 34360965 | PubTator, text mining | PubMed |
| Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma. | Cancer Cell Int | 2021 | 34344378 | PubTator, text mining | PubMed |
| Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis. | Arterioscler Thromb Vasc Biol | 2021 | 34320835 | PubTator, text mining | PubMed |
| Ghrelin octanoylation by ghrelin O-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling. | Open Biol | 2021 | 34315274 | PubTator, text mining | PubMed |
| Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma. | Front Oncol | 2021 | 34307154 | PubTator, text mining | PubMed |
| Statins: a repurposed drug to fight cancer. | J Exp Clin Cancer Res | 2021 | 34303383 | PubTator, text mining | PubMed |
| Expanding the genotypes and phenotypes for 19 rare diseases by exome sequencing performed in pediatric intensive care unit. | Hum Mutat | 2021 | 34298581 | PubTator, text mining | PubMed |
| Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells. | Mol Cell | 2021 | 34289383 | PubTator, text mining | PubMed |
| Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 34285143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=47